Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pomel

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 7, 2014
[How to surgery for advanced ovarian serous cancers?]F Lécuru, J-M Classe, P Collinet, et al.
Gynecologie, Obstetrique & Fertilite|July 29, 2008
[Ovarian epithelial dysplasia: myth or reality? Review]G Chêne, F Penault-Llorca, G Le Bouëdec, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2015
[Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure]A Bellière-Calandry, C Benoît, S Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2009
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancerJ Dauplat, G Chene, C Pomel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2013
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patientsN Bakrin, J M Bereder, E Decullier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2017
Networking for ovarian rare tumors: a significant breakthrough improving disease managementN Chiannilkulchai, P Pautier, C Genestie, et al.
Gynecologic Oncology|March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group StudyC Lenck, N Chopin, S Gouy, et al.
Gynecologic Oncology|July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG networkF Derquin, A Floquet, A C Hardy-Bessard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 13, 2015
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric surveyG Ferron, L Simon, F Guyon, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 7, 2014
[How to surgery for advanced ovarian serous cancers?]F Lécuru, J-M Classe, P Collinet, et al.
Gynecologie, Obstetrique & Fertilite|July 29, 2008
[Ovarian epithelial dysplasia: myth or reality? Review]G Chêne, F Penault-Llorca, G Le Bouëdec, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2015
[Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure]A Bellière-Calandry, C Benoît, S Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2009
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancerJ Dauplat, G Chene, C Pomel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2013
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patientsN Bakrin, J M Bereder, E Decullier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2017
Networking for ovarian rare tumors: a significant breakthrough improving disease managementN Chiannilkulchai, P Pautier, C Genestie, et al.
Gynecologic Oncology|March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group StudyC Lenck, N Chopin, S Gouy, et al.
Gynecologic Oncology|July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG networkF Derquin, A Floquet, A C Hardy-Bessard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 13, 2015
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric surveyG Ferron, L Simon, F Guyon, et al.
Pageof 8